Efficacy and Safety of Immersive Virtual Reality for Post-stroke Cognitive Impairment

Launched by DINGQUN BAI · Nov 23, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the use of immersive virtual reality (VR) as a possible treatment for people who have experienced cognitive decline after a stroke. Cognitive decline refers to difficulties with thinking, memory, and understanding. The researchers want to see if using VR can help improve these skills in stroke survivors, making it easier for them to recover and regain their independence.

To participate in this trial, you must be between 18 and 85 years old and have had a stroke confirmed by imaging tests like a CT scan or MRI. It’s important that you can follow instructions and tolerate the rehabilitation exercises involved in the study. Participants will not be able to join if they have serious mental health issues, cannot handle the test due to other health problems, or are already enrolled in another clinical trial. If you qualify and choose to take part, you will engage in VR activities aimed at improving your cognitive function while being monitored for safety. The trial is not yet recruiting participants, but it aims to provide insights into how VR might benefit stroke survivors.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Diagnosis of stroke by neuroimaging (CT or MRI) assessment
• • 2. 18-85 years old
• • 3. Be able to follow instructions to complete the test
• • 4. Can tolerate the rehabilitation training of this experiment
• • 5. First stroke
• • 6. Patients who signed informed consent
• Exclusion Criteria:
• • 1. The test could not be tolerated due to organic disease
• • 2. There is a serious mental illness resulting in inability to cooperate with or tolerate this test
• • 3. is participating in another clinical trial involving an investigational drug or physical therapy
• • 4. Patients who have not signed informed consent